CXCL10 and Bartsocas-Papas syndrome 1: Using a cluster of urinary biomarkers, namely TNF-α or 8-OHdG and 8-isoprostane, can identify patients with IC/BPS from a study cohort, and adding the urinary IP-10 can detect patients with HIC from an IC/BPS cohort.